| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutropenia | 19 | 2026 | 69 | 5.190 |
Why?
|
| Granulomatous Disease, Chronic | 34 | 2020 | 41 | 2.840 |
Why?
|
| NADPH Oxidases | 31 | 2020 | 71 | 2.130 |
Why?
|
| Leukocyte Elastase | 6 | 2024 | 14 | 1.830 |
Why?
|
| Neutrophils | 32 | 2025 | 394 | 1.650 |
Why?
|
| Interferon-gamma | 15 | 2018 | 581 | 1.270 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 8 | 2022 | 41 | 1.260 |
Why?
|
| Glutathione Peroxidase | 14 | 2006 | 29 | 1.240 |
Why?
|
| Membrane Glycoproteins | 19 | 2015 | 668 | 1.200 |
Why?
|
| Phagocytes | 14 | 2015 | 52 | 1.170 |
Why?
|
| Selenocysteine | 7 | 2006 | 15 | 1.000 |
Why?
|
| Myelodysplastic Syndromes | 5 | 2022 | 93 | 0.910 |
Why?
|
| Medical Oncology | 3 | 2015 | 68 | 0.900 |
Why?
|
| Gene Expression | 15 | 2019 | 866 | 0.900 |
Why?
|
| RNA, Messenger | 27 | 2018 | 1588 | 0.840 |
Why?
|
| Codon, Nonsense | 1 | 2024 | 61 | 0.820 |
Why?
|
| RNA, Long Noncoding | 3 | 2018 | 172 | 0.820 |
Why?
|
| Cytochrome b Group | 16 | 1998 | 20 | 0.820 |
Why?
|
| Gene Expression Regulation | 17 | 2021 | 1641 | 0.810 |
Why?
|
| Superoxides | 33 | 2004 | 73 | 0.790 |
Why?
|
| Granulocytes | 23 | 2008 | 73 | 0.780 |
Why?
|
| Humans | 167 | 2026 | 65446 | 0.780 |
Why?
|
| Mutation | 22 | 2021 | 2687 | 0.760 |
Why?
|
| Cell Differentiation | 26 | 2015 | 1394 | 0.730 |
Why?
|
| B-Lymphocytes | 11 | 2018 | 569 | 0.720 |
Why?
|
| Genetic Therapy | 4 | 2024 | 836 | 0.720 |
Why?
|
| Receptors, Interferon | 2 | 2018 | 20 | 0.690 |
Why?
|
| Leukemia, Promyelocytic, Acute | 7 | 2014 | 18 | 0.600 |
Why?
|
| Hematology | 3 | 2015 | 12 | 0.600 |
Why?
|
| Prenatal Diagnosis | 3 | 2018 | 41 | 0.600 |
Why?
|
| Anemia, Sickle Cell | 2 | 2018 | 68 | 0.590 |
Why?
|
| Autoimmune Diseases | 3 | 2016 | 242 | 0.580 |
Why?
|
| Neoplasms | 6 | 2021 | 1409 | 0.580 |
Why?
|
| Y-Box-Binding Protein 1 | 4 | 2006 | 6 | 0.570 |
Why?
|
| Transcription Factors | 12 | 2009 | 1558 | 0.560 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2026 | 74 | 0.550 |
Why?
|
| Exons | 11 | 2024 | 208 | 0.550 |
Why?
|
| Hematologic Diseases | 4 | 2003 | 12 | 0.530 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 46 | 0.520 |
Why?
|
| NF-kappa B | 3 | 2015 | 475 | 0.520 |
Why?
|
| Hematopoietic Stem Cells | 15 | 2020 | 301 | 0.510 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2016 | 4 | 0.510 |
Why?
|
| Phosphoproteins | 8 | 2006 | 223 | 0.510 |
Why?
|
| Heterozygote | 3 | 2016 | 175 | 0.500 |
Why?
|
| Monocytes | 10 | 2008 | 363 | 0.500 |
Why?
|
| Hemoglobin C | 1 | 2016 | 2 | 0.490 |
Why?
|
| Anemia, Hypochromic | 1 | 2016 | 5 | 0.490 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2016 | 6 | 0.490 |
Why?
|
| Anemia, Diamond-Blackfan | 5 | 2018 | 9 | 0.490 |
Why?
|
| Myelopoiesis | 2 | 2009 | 13 | 0.490 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2013 | 10 | 0.480 |
Why?
|
| Cell Line | 22 | 2018 | 2068 | 0.470 |
Why?
|
| Infant | 14 | 2024 | 1702 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2009 | 664 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2021 | 743 | 0.450 |
Why?
|
| Transcription, Genetic | 17 | 2008 | 922 | 0.440 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 425 | 0.440 |
Why?
|
| Pyruvate Kinase | 3 | 2020 | 11 | 0.440 |
Why?
|
| NADPH Oxidase 2 | 15 | 2015 | 36 | 0.430 |
Why?
|
| Leukemia, Myeloid, Acute | 14 | 2015 | 193 | 0.420 |
Why?
|
| Genes, Homeobox | 1 | 2013 | 24 | 0.410 |
Why?
|
| Child | 24 | 2025 | 4665 | 0.400 |
Why?
|
| Cell Cycle | 3 | 2014 | 403 | 0.390 |
Why?
|
| Inheritance Patterns | 2 | 2010 | 20 | 0.390 |
Why?
|
| DNA-Binding Proteins | 6 | 2008 | 1224 | 0.390 |
Why?
|
| Leukemia | 5 | 2019 | 61 | 0.380 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 180 | 0.380 |
Why?
|
| Tretinoin | 7 | 2014 | 51 | 0.370 |
Why?
|
| Ribosomal Proteins | 5 | 2018 | 44 | 0.370 |
Why?
|
| Biomedical Research | 1 | 2015 | 271 | 0.370 |
Why?
|
| DNA Transposable Elements | 2 | 2006 | 160 | 0.370 |
Why?
|
| Base Sequence | 20 | 2015 | 1341 | 0.360 |
Why?
|
| Gene Expression Profiling | 10 | 2014 | 803 | 0.340 |
Why?
|
| Phenotype | 7 | 2018 | 1242 | 0.330 |
Why?
|
| Molecular Sequence Data | 19 | 2015 | 2003 | 0.330 |
Why?
|
| Pediatrics | 2 | 2015 | 266 | 0.320 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 122 | 0.320 |
Why?
|
| Haplotypes | 1 | 2010 | 134 | 0.320 |
Why?
|
| RNA-Binding Proteins | 3 | 2000 | 458 | 0.320 |
Why?
|
| Lipopolysaccharides | 5 | 2003 | 630 | 0.300 |
Why?
|
| Piebaldism | 1 | 2009 | 1 | 0.300 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2009 | 2 | 0.300 |
Why?
|
| Pyruvate Metabolism, Inborn Errors | 2 | 2020 | 3 | 0.300 |
Why?
|
| Anemia, Hemolytic, Congenital Nonspherocytic | 2 | 2020 | 3 | 0.300 |
Why?
|
| Phagocytosis | 14 | 2016 | 267 | 0.300 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2009 | 7 | 0.300 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2000 | 28 | 0.300 |
Why?
|
| Male | 46 | 2026 | 31070 | 0.300 |
Why?
|
| Child, Preschool | 16 | 2025 | 2069 | 0.300 |
Why?
|
| NADH, NADPH Oxidoreductases | 8 | 1994 | 18 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2015 | 302 | 0.300 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 24 | 0.300 |
Why?
|
| Periodicity | 1 | 2009 | 49 | 0.300 |
Why?
|
| Tetradecanoylphorbol Acetate | 14 | 1998 | 66 | 0.290 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2018 | 358 | 0.290 |
Why?
|
| Animals | 41 | 2025 | 21570 | 0.290 |
Why?
|
| Pedigree | 8 | 2026 | 199 | 0.280 |
Why?
|
| Cytokines | 7 | 2016 | 958 | 0.280 |
Why?
|
| Dog Diseases | 1 | 2009 | 64 | 0.280 |
Why?
|
| Polyploidy | 1 | 2008 | 13 | 0.280 |
Why?
|
| Chronic Disease | 6 | 2022 | 754 | 0.280 |
Why?
|
| Mosaicism | 1 | 2008 | 30 | 0.280 |
Why?
|
| Neutrophil Activation | 4 | 2008 | 23 | 0.280 |
Why?
|
| Primary Myelofibrosis | 2 | 2018 | 11 | 0.280 |
Why?
|
| Tumor Cells, Cultured | 12 | 1998 | 466 | 0.270 |
Why?
|
| Germ-Line Mutation | 2 | 2026 | 49 | 0.270 |
Why?
|
| Awards and Prizes | 1 | 2008 | 34 | 0.270 |
Why?
|
| RNA Splicing | 3 | 2019 | 165 | 0.270 |
Why?
|
| Bone Marrow | 9 | 2025 | 176 | 0.270 |
Why?
|
| Recombinant Proteins | 12 | 2008 | 715 | 0.270 |
Why?
|
| Dogs | 1 | 2009 | 343 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2013 | 626 | 0.260 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 277 | 0.260 |
Why?
|
| Carotid Arteries | 1 | 2007 | 63 | 0.250 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 55 | 0.250 |
Why?
|
| Vesicular Transport Proteins | 2 | 2018 | 118 | 0.250 |
Why?
|
| Embryo Loss | 1 | 2006 | 14 | 0.250 |
Why?
|
| Fetal Blood | 4 | 1996 | 73 | 0.250 |
Why?
|
| Selenium | 4 | 1993 | 25 | 0.250 |
Why?
|
| X Chromosome | 8 | 1998 | 51 | 0.250 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 181 | 0.240 |
Why?
|
| Adolescent | 19 | 2025 | 6358 | 0.240 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2010 | 50 | 0.240 |
Why?
|
| Lymphopenia | 1 | 2026 | 35 | 0.240 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 134 | 0.240 |
Why?
|
| Herpesvirus 4, Human | 6 | 2018 | 198 | 0.240 |
Why?
|
| Cytokinesis | 1 | 2026 | 41 | 0.230 |
Why?
|
| Genomics | 3 | 2007 | 394 | 0.230 |
Why?
|
| Cells, Cultured | 20 | 2009 | 2212 | 0.230 |
Why?
|
| Protein Biosynthesis | 6 | 2006 | 333 | 0.230 |
Why?
|
| Chromosomes, Human, X | 2 | 2020 | 36 | 0.230 |
Why?
|
| Leukemia, Myeloid | 8 | 2006 | 36 | 0.230 |
Why?
|
| Warts | 1 | 2025 | 7 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 4 | 2020 | 696 | 0.230 |
Why?
|
| Genetic Testing | 2 | 2019 | 142 | 0.230 |
Why?
|
| Receptors, CXCR4 | 1 | 2025 | 43 | 0.220 |
Why?
|
| Oxygen | 7 | 1983 | 325 | 0.220 |
Why?
|
| Leukocytes | 5 | 2008 | 105 | 0.220 |
Why?
|
| Nucleic Acid Conformation | 4 | 2006 | 242 | 0.210 |
Why?
|
| RNA Splice Sites | 3 | 2019 | 23 | 0.210 |
Why?
|
| Polymorphism, Genetic | 3 | 1994 | 199 | 0.210 |
Why?
|
| Respiratory Burst | 5 | 2011 | 21 | 0.210 |
Why?
|
| Myeloid Cells | 3 | 2016 | 98 | 0.210 |
Why?
|
| HL-60 Cells | 3 | 2015 | 25 | 0.200 |
Why?
|
| Cell Transformation, Viral | 4 | 1998 | 15 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 10 | 2003 | 519 | 0.200 |
Why?
|
| Female | 33 | 2026 | 34099 | 0.200 |
Why?
|
| Transfection | 9 | 1998 | 706 | 0.200 |
Why?
|
| Cluster Analysis | 3 | 2014 | 264 | 0.200 |
Why?
|
| Macrophages | 10 | 2011 | 1063 | 0.190 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 288 | 0.190 |
Why?
|
| Infant, Newborn | 9 | 2021 | 1444 | 0.190 |
Why?
|
| Repressor Proteins | 2 | 2009 | 358 | 0.190 |
Why?
|
| Clinical Trials as Topic | 2 | 2004 | 465 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2009 | 710 | 0.180 |
Why?
|
| Protein Binding | 5 | 2015 | 1649 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 550 | 0.180 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2305 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1608 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2015 | 181 | 0.170 |
Why?
|
| History, 20th Century | 2 | 2015 | 235 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2013 | 619 | 0.170 |
Why?
|
| Oxygen Consumption | 9 | 1995 | 213 | 0.160 |
Why?
|
| Genes, X-Linked | 2 | 2011 | 22 | 0.160 |
Why?
|
| Proteomics | 1 | 2002 | 311 | 0.160 |
Why?
|
| RNA, Small Interfering | 5 | 2013 | 971 | 0.160 |
Why?
|
| Stem Cells | 2 | 2016 | 275 | 0.160 |
Why?
|
| Young Adult | 9 | 2025 | 4817 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 106 | 0.160 |
Why?
|
| Leukocyte Count | 3 | 2015 | 100 | 0.160 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2014 | 52 | 0.160 |
Why?
|
| Lentivirus | 1 | 2020 | 67 | 0.150 |
Why?
|
| Adult | 20 | 2025 | 17387 | 0.150 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2019 | 2 | 0.150 |
Why?
|
| Spectrin | 1 | 2019 | 8 | 0.150 |
Why?
|
| Point Mutation | 3 | 2000 | 169 | 0.150 |
Why?
|
| Lymphoma | 3 | 2019 | 103 | 0.150 |
Why?
|
| Gene Silencing | 2 | 2020 | 421 | 0.150 |
Why?
|
| Alternative Splicing | 1 | 2000 | 138 | 0.150 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 26 | 0.150 |
Why?
|
| Hematopoietic System | 1 | 2018 | 10 | 0.150 |
Why?
|
| Mice | 20 | 2025 | 11243 | 0.150 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2018 | 3 | 0.150 |
Why?
|
| Iron Overload | 1 | 2018 | 5 | 0.150 |
Why?
|
| Indomethacin | 1 | 1998 | 23 | 0.140 |
Why?
|
| HeLa Cells | 4 | 2013 | 553 | 0.140 |
Why?
|
| Trisomy | 1 | 2018 | 22 | 0.140 |
Why?
|
| Neutrophil Infiltration | 2 | 2016 | 64 | 0.140 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 71 | 0.140 |
Why?
|
| Photosystem II Protein Complex | 2 | 1988 | 9 | 0.140 |
Why?
|
| Cloning, Molecular | 6 | 1998 | 386 | 0.140 |
Why?
|
| Rats | 7 | 2010 | 2017 | 0.140 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 19 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2019 | 190 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 54 | 0.140 |
Why?
|
| Down Syndrome | 1 | 2018 | 47 | 0.140 |
Why?
|
| Proteins | 3 | 2002 | 766 | 0.130 |
Why?
|
| Dexamethasone | 1 | 1998 | 211 | 0.130 |
Why?
|
| Bone Marrow Cells | 6 | 2006 | 240 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1998 | 175 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 205 | 0.130 |
Why?
|
| Phenylpropionates | 1 | 2016 | 10 | 0.130 |
Why?
|
| Whole-Body Irradiation | 1 | 2016 | 33 | 0.130 |
Why?
|
| RNA, Ribosomal | 3 | 2013 | 60 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 376 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 207 | 0.120 |
Why?
|
| Receptors, Somatotropin | 1 | 1996 | 3 | 0.120 |
Why?
|
| Hematopoiesis | 8 | 2018 | 127 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2018 | 316 | 0.120 |
Why?
|
| Pregnancy | 6 | 2018 | 2422 | 0.120 |
Why?
|
| DNA Mutational Analysis | 6 | 2018 | 199 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 594 | 0.120 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1996 | 27 | 0.120 |
Why?
|
| Leukemia, Monocytic, Acute | 2 | 2010 | 4 | 0.120 |
Why?
|
| Binding Sites | 2 | 2015 | 929 | 0.120 |
Why?
|
| Multigene Family | 2 | 2009 | 106 | 0.120 |
Why?
|
| Apoptosis | 2 | 2013 | 1112 | 0.120 |
Why?
|
| Codon | 3 | 1993 | 59 | 0.120 |
Why?
|
| Anemia, Sideroblastic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Sequence Deletion | 4 | 2006 | 116 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 10 | 0.120 |
Why?
|
| Salicylates | 1 | 2015 | 9 | 0.120 |
Why?
|
| Spleen | 3 | 2016 | 479 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 3 | 2006 | 94 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 317 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2018 | 3155 | 0.110 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2015 | 6 | 0.110 |
Why?
|
| Mycobacterium Infections | 1 | 2014 | 15 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2016 | 295 | 0.110 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 81 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2022 | 3340 | 0.110 |
Why?
|
| Minisatellite Repeats | 1 | 1994 | 6 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 108 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2009 | 236 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 38 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 471 | 0.110 |
Why?
|
| Superoxide Dismutase | 3 | 2004 | 226 | 0.110 |
Why?
|
| Blotting, Northern | 5 | 2012 | 152 | 0.110 |
Why?
|
| Genome, Human | 2 | 2007 | 242 | 0.110 |
Why?
|
| Integrin alpha4 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 1994 | 12 | 0.110 |
Why?
|
| CD11c Antigen | 1 | 2014 | 8 | 0.110 |
Why?
|
| RNA | 6 | 2006 | 431 | 0.110 |
Why?
|
| Escherichia coli | 4 | 2003 | 725 | 0.110 |
Why?
|
| Genetic Linkage | 7 | 1998 | 98 | 0.100 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 48 | 0.100 |
Why?
|
| United States | 4 | 2020 | 8121 | 0.100 |
Why?
|
| Annexin A5 | 1 | 2013 | 21 | 0.100 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 4 | 2003 | 19 | 0.100 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cell Division | 3 | 2007 | 457 | 0.100 |
Why?
|
| Genotype | 5 | 2018 | 678 | 0.100 |
Why?
|
| Cell Line, Transformed | 3 | 2008 | 99 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 157 | 0.090 |
Why?
|
| Phorbols | 3 | 1981 | 3 | 0.090 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 4 | 2006 | 16 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2008 | 72 | 0.090 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 29 | 0.090 |
Why?
|
| RNA Polymerase II | 2 | 2009 | 88 | 0.090 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 104 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2007 | 103 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 598 | 0.090 |
Why?
|
| DNA, Complementary | 4 | 2004 | 167 | 0.090 |
Why?
|
| Erythropoietin | 2 | 2009 | 41 | 0.090 |
Why?
|
| K562 Cells | 2 | 2009 | 59 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1993 | 185 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 431 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2005 | 247 | 0.080 |
Why?
|
| Hyperplasia | 2 | 2010 | 90 | 0.080 |
Why?
|
| Retroviridae | 3 | 1989 | 75 | 0.080 |
Why?
|
| Species Specificity | 3 | 2009 | 349 | 0.080 |
Why?
|
| Toll-Like Receptors | 3 | 2008 | 435 | 0.080 |
Why?
|
| Fathers | 1 | 2010 | 22 | 0.080 |
Why?
|
| Nitroblue Tetrazolium | 7 | 1995 | 8 | 0.080 |
Why?
|
| Middle Aged | 9 | 2025 | 18274 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1990 | 214 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 1993 | 312 | 0.080 |
Why?
|
| Inflammation | 2 | 2016 | 1188 | 0.080 |
Why?
|
| NADPH Dehydrogenase | 2 | 1996 | 4 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 4 | 1988 | 140 | 0.080 |
Why?
|
| Protein Transport | 2 | 2009 | 413 | 0.080 |
Why?
|
| Receptors, Transferrin | 1 | 1990 | 33 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 321 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1048 | 0.080 |
Why?
|
| Leukemia, Experimental | 4 | 1982 | 19 | 0.080 |
Why?
|
| alpha-Globins | 1 | 2009 | 5 | 0.080 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2009 | 3 | 0.080 |
Why?
|
| Genes | 4 | 1996 | 90 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 631 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 214 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2018 | 393 | 0.080 |
Why?
|
| NFI Transcription Factors | 2 | 2000 | 7 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2009 | 21 | 0.070 |
Why?
|
| Cytoplasmic Granules | 3 | 1985 | 53 | 0.070 |
Why?
|
| Erythroid Precursor Cells | 1 | 2009 | 25 | 0.070 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2009 | 39 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 2009 | 39 | 0.070 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2009 | 9 | 0.070 |
Why?
|
| Transplantation Conditioning | 2 | 2020 | 101 | 0.070 |
Why?
|
| Amino Acid Sequence | 6 | 2000 | 1608 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2008 | 380 | 0.070 |
Why?
|
| Thumb | 1 | 2008 | 27 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2009 | 110 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 55 | 0.070 |
Why?
|
| Cell Lineage | 3 | 2004 | 283 | 0.070 |
Why?
|
| Ectodermal Dysplasia | 1 | 2008 | 6 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2010 | 160 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 367 | 0.070 |
Why?
|
| Sepsis | 2 | 2017 | 291 | 0.070 |
Why?
|
| Cleft Palate | 1 | 2008 | 40 | 0.070 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2008 | 27 | 0.070 |
Why?
|
| DNA Primers | 4 | 1998 | 302 | 0.070 |
Why?
|
| Leukopenia | 1 | 2008 | 15 | 0.070 |
Why?
|
| Spermatozoa | 1 | 2010 | 265 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2008 | 57 | 0.070 |
Why?
|
| Paraproteinemias | 1 | 2008 | 16 | 0.070 |
Why?
|
| Gene Frequency | 2 | 2021 | 125 | 0.070 |
Why?
|
| Lymphoma, Follicular | 1 | 2008 | 15 | 0.070 |
Why?
|
| Syndrome | 2 | 2007 | 178 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1990 | 347 | 0.070 |
Why?
|
| Classification | 1 | 2007 | 13 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2010 | 303 | 0.070 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1998 | 11 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2008 | 132 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 374 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 3490 | 0.070 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2007 | 24 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2011 | 305 | 0.060 |
Why?
|
| Nuclear Proteins | 3 | 2006 | 793 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 384 | 0.060 |
Why?
|
| Blood Transfusion | 2 | 2018 | 162 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 75 | 0.060 |
Why?
|
| Catalase | 1 | 1986 | 23 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 216 | 0.060 |
Why?
|
| Disease Management | 2 | 2019 | 238 | 0.060 |
Why?
|
| Glutathione | 1 | 1986 | 58 | 0.060 |
Why?
|
| Germinal Center | 1 | 2006 | 39 | 0.060 |
Why?
|
| Time Factors | 9 | 2004 | 3781 | 0.060 |
Why?
|
| NADP | 2 | 1983 | 22 | 0.060 |
Why?
|
| Mitosis | 1 | 2008 | 223 | 0.060 |
Why?
|
| Oxidoreductases | 2 | 2001 | 65 | 0.060 |
Why?
|
| Eosinophilia | 1 | 2006 | 37 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2005 | 95 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 303 | 0.060 |
Why?
|
| Blastocyst | 1 | 2006 | 75 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2002 | 40 | 0.060 |
Why?
|
| Hydrogen Peroxide | 5 | 1986 | 86 | 0.060 |
Why?
|
| Colostrum | 1 | 2005 | 6 | 0.060 |
Why?
|
| Antigens, CD34 | 2 | 2020 | 53 | 0.060 |
Why?
|
| Immunoglobulin E | 5 | 1983 | 84 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 880 | 0.060 |
Why?
|
| Agammaglobulinemia | 1 | 2025 | 9 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 1986 | 74 | 0.060 |
Why?
|
| Chediak-Higashi Syndrome | 1 | 1985 | 3 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2007 | 323 | 0.060 |
Why?
|
| Computational Biology | 1 | 2007 | 367 | 0.060 |
Why?
|
| In Vitro Techniques | 5 | 2008 | 497 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2010 | 928 | 0.050 |
Why?
|
| Leukemia, Lymphoid | 3 | 1981 | 11 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2005 | 52 | 0.050 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2004 | 3 | 0.050 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 1984 | 3 | 0.050 |
Why?
|
| Leukapheresis | 1 | 1984 | 11 | 0.050 |
Why?
|
| COS Cells | 2 | 2004 | 182 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2010 | 545 | 0.050 |
Why?
|
| DNA | 6 | 2004 | 856 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2002 | 315 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2004 | 140 | 0.050 |
Why?
|
| Virulence | 2 | 2021 | 202 | 0.050 |
Why?
|
| Blood Bactericidal Activity | 4 | 1988 | 61 | 0.050 |
Why?
|
| Eosinophils | 1 | 2003 | 49 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 115 | 0.050 |
Why?
|
| Age Factors | 3 | 2005 | 1591 | 0.050 |
Why?
|
| RNA Interference | 1 | 2007 | 642 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2021 | 401 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2020 | 5819 | 0.050 |
Why?
|
| Dimethylformamide | 3 | 1994 | 3 | 0.050 |
Why?
|
| Starch | 1 | 1984 | 83 | 0.050 |
Why?
|
| Concanavalin A | 1 | 1982 | 40 | 0.050 |
Why?
|
| Hydroxides | 1 | 1982 | 7 | 0.050 |
Why?
|
| Actins | 1 | 2004 | 263 | 0.050 |
Why?
|
| Pneumonia | 1 | 1986 | 293 | 0.050 |
Why?
|
| Alleles | 3 | 2001 | 457 | 0.050 |
Why?
|
| Anemia | 1 | 2004 | 131 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 55 | 0.050 |
Why?
|
| Research | 1 | 2004 | 196 | 0.050 |
Why?
|
| Genetic Vectors | 5 | 2020 | 918 | 0.050 |
Why?
|
| Antibody Formation | 4 | 1974 | 111 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2004 | 510 | 0.050 |
Why?
|
| Models, Animal | 2 | 2015 | 241 | 0.050 |
Why?
|
| Esophagitis | 2 | 1979 | 9 | 0.050 |
Why?
|
| Oxidation-Reduction | 7 | 1996 | 331 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1155 | 0.040 |
Why?
|
| Kinetics | 5 | 1992 | 766 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 1979 | 130 | 0.040 |
Why?
|
| Zymosan | 4 | 1982 | 25 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 1989 | 639 | 0.040 |
Why?
|
| Doxorubicin | 2 | 1979 | 105 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 1698 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1999 | 51 | 0.040 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 25 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 24 | 0.040 |
Why?
|
| RNA, Viral | 2 | 2008 | 268 | 0.040 |
Why?
|
| Yersinia pestis | 1 | 2001 | 33 | 0.040 |
Why?
|
| Genes, Recessive | 2 | 2006 | 54 | 0.040 |
Why?
|
| Peroxidase | 4 | 2003 | 70 | 0.040 |
Why?
|
| Biomarkers | 3 | 2018 | 1474 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 1795 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 35 | 0.040 |
Why?
|
| Proteome | 1 | 2001 | 161 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 2020 | 28 | 0.040 |
Why?
|
| Asthma | 1 | 2004 | 472 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1985 | 62 | 0.040 |
Why?
|
| United Kingdom | 1 | 2020 | 85 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 102 | 0.040 |
Why?
|
| Membrane Potentials | 5 | 1990 | 141 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1979 | 16 | 0.040 |
Why?
|
| Neomycin | 2 | 1989 | 6 | 0.040 |
Why?
|
| Sex Chromatin | 1 | 1979 | 10 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 5619 | 0.040 |
Why?
|
| Precipitin Tests | 3 | 1995 | 78 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2019 | 2101 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 878 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 67 | 0.040 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 1998 | 3 | 0.040 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 1998 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2018 | 30 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1999 | 245 | 0.040 |
Why?
|
| Esophageal Stenosis | 1 | 1978 | 5 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 1990 | 297 | 0.040 |
Why?
|
| Exome | 1 | 2018 | 78 | 0.040 |
Why?
|
| Aged | 4 | 2021 | 14956 | 0.040 |
Why?
|
| Lysosomes | 1 | 1979 | 171 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1998 | 12 | 0.030 |
Why?
|
| Gene Products, tat | 1 | 1998 | 14 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2002 | 434 | 0.030 |
Why?
|
| Selenoproteins | 1 | 1998 | 8 | 0.030 |
Why?
|
| Iodide Peroxidase | 1 | 1998 | 23 | 0.030 |
Why?
|
| Thrombopoietin | 1 | 1998 | 11 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 2018 | 34 | 0.030 |
Why?
|
| Splenectomy | 1 | 2018 | 39 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 388 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2018 | 49 | 0.030 |
Why?
|
| Serine | 1 | 1998 | 92 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 1978 | 67 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1998 | 45 | 0.030 |
Why?
|
| Iron | 1 | 2018 | 156 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2002 | 531 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 127 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 182 | 0.030 |
Why?
|
| Cricetinae | 2 | 2011 | 370 | 0.030 |
Why?
|
| Patient Safety | 1 | 2020 | 247 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 125 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 165 | 0.030 |
Why?
|
| Papio | 1 | 2016 | 21 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2009 | 219 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 758 | 0.030 |
Why?
|
| Radiation Exposure | 1 | 2016 | 24 | 0.030 |
Why?
|
| Ribosomes | 1 | 2018 | 173 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1126 | 0.030 |
Why?
|
| Gene Editing | 1 | 2021 | 333 | 0.030 |
Why?
|
| T-Lymphocytes | 4 | 1980 | 1011 | 0.030 |
Why?
|
| Deoxyglucose | 4 | 1993 | 32 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2000 | 878 | 0.030 |
Why?
|
| Laminin | 1 | 1996 | 81 | 0.030 |
Why?
|
| Luciferases | 1 | 1996 | 109 | 0.030 |
Why?
|
| HIV | 1 | 1995 | 70 | 0.030 |
Why?
|
| Plasmids | 1 | 1996 | 297 | 0.030 |
Why?
|
| Calcium | 4 | 1996 | 591 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 185 | 0.030 |
Why?
|
| Extracellular Traps | 1 | 2015 | 47 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1994 | 44 | 0.030 |
Why?
|
| Live Birth | 1 | 2015 | 21 | 0.030 |
Why?
|
| Fibrosis | 1 | 2015 | 173 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1995 | 343 | 0.030 |
Why?
|
| Histones | 2 | 2009 | 499 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2015 | 31 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 1996 | 115 | 0.030 |
Why?
|
| TATA Box | 1 | 1994 | 11 | 0.030 |
Why?
|
| Obstetric Labor, Premature | 1 | 2015 | 31 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1994 | 30 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 1996 | 200 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 1994 | 63 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 739 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1974 | 45 | 0.030 |
Why?
|
| Minority Groups | 1 | 1996 | 143 | 0.030 |
Why?
|
| Recurrence | 2 | 2010 | 663 | 0.030 |
Why?
|
| Ligands | 2 | 2008 | 419 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 860 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1439 | 0.030 |
Why?
|
| Gestational Age | 1 | 2015 | 199 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 906 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 2 | 1974 | 236 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cyclic AMP | 2 | 1985 | 145 | 0.030 |
Why?
|
| Automation | 2 | 2003 | 55 | 0.020 |
Why?
|
| Microspheres | 2 | 2003 | 57 | 0.020 |
Why?
|
| Introns | 2 | 2006 | 114 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2005 | 222 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2003 | 46 | 0.020 |
Why?
|
| Immunoblotting | 2 | 1992 | 207 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 74 | 0.020 |
Why?
|
| Ethylmaleimide | 3 | 1982 | 8 | 0.020 |
Why?
|
| Biotechnology | 2 | 2003 | 46 | 0.020 |
Why?
|
| Mass Screening | 1 | 2019 | 705 | 0.020 |
Why?
|
| Epitopes | 2 | 1993 | 294 | 0.020 |
Why?
|
| Blood Cells | 2 | 2004 | 17 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 510 | 0.020 |
Why?
|
| Cell Movement | 2 | 1985 | 478 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2624 | 0.020 |
Why?
|
| Immunoglobulin G | 4 | 1974 | 468 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2509 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2003 | 319 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1991 | 32 | 0.020 |
Why?
|
| Temperature | 3 | 1982 | 315 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1994 | 593 | 0.020 |
Why?
|
| Opsonin Proteins | 2 | 1981 | 32 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 977 | 0.020 |
Why?
|
| Qa-SNARE Proteins | 1 | 2010 | 19 | 0.020 |
Why?
|
| Luminescent Measurements | 3 | 1998 | 40 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1990 | 47 | 0.020 |
Why?
|
| Perforin | 1 | 2010 | 31 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 101 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 190 | 0.020 |
Why?
|
| Cytochrome c Group | 3 | 1991 | 25 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 52 | 0.020 |
Why?
|
| Neointima | 1 | 2010 | 19 | 0.020 |
Why?
|
| Expressed Sequence Tags | 2 | 2001 | 28 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 1168 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1990 | 56 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1989 | 22 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 111 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 100 | 0.020 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2009 | 1 | 0.020 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2009 | 4 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2009 | 7 | 0.020 |
Why?
|
| Insulator Elements | 1 | 2009 | 5 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1989 | 57 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2011 | 153 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 50 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 1990 | 52 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 34 | 0.020 |
Why?
|
| CCCTC-Binding Factor | 1 | 2009 | 40 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1993 | 471 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 58 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2010 | 104 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2248 | 0.020 |
Why?
|
| Ribosome Subunits, Small | 1 | 2008 | 3 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1990 | 113 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1989 | 23 | 0.020 |
Why?
|
| Ribosome Subunits, Large | 1 | 2008 | 4 | 0.020 |
Why?
|
| Rituximab | 1 | 2009 | 88 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 119 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1988 | 70 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1989 | 156 | 0.020 |
Why?
|
| Macrolides | 1 | 2008 | 38 | 0.020 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2008 | 50 | 0.020 |
Why?
|
| Dinitrophenols | 4 | 1974 | 5 | 0.020 |
Why?
|
| International Cooperation | 1 | 1988 | 88 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 142 | 0.020 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2008 | 104 | 0.020 |
Why?
|
| Virus Internalization | 1 | 2008 | 91 | 0.020 |
Why?
|
| Australia | 1 | 2007 | 129 | 0.020 |
Why?
|
| Basophils | 1 | 1987 | 15 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2007 | 51 | 0.020 |
Why?
|
| HIV-1 | 1 | 1992 | 711 | 0.020 |
Why?
|
| Tissue Donors | 1 | 1988 | 155 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2006 | 8 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2006 | 16 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2006 | 18 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2006 | 9 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Biopsy | 2 | 2006 | 456 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2007 | 175 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 997 | 0.020 |
Why?
|
| Osteopetrosis | 1 | 1986 | 24 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1986 | 36 | 0.020 |
Why?
|
| Flavoproteins | 1 | 1986 | 29 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 1986 | 18 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 324 | 0.020 |
Why?
|
| Thalassemia | 1 | 1986 | 4 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2007 | 105 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 147 | 0.020 |
Why?
|
| Karyotyping | 1 | 2006 | 48 | 0.020 |
Why?
|
| Globins | 1 | 1986 | 25 | 0.020 |
Why?
|
| Aspergillosis | 1 | 1986 | 41 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1988 | 196 | 0.020 |
Why?
|
| Guinea Pigs | 3 | 1981 | 86 | 0.020 |
Why?
|
| Latin America | 1 | 2006 | 17 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2006 | 70 | 0.010 |
Why?
|
| Abscess | 1 | 1986 | 79 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 169 | 0.010 |
Why?
|
| HIV Infections | 1 | 1992 | 956 | 0.010 |
Why?
|
| Pentose Phosphate Pathway | 1 | 1985 | 7 | 0.010 |
Why?
|
| Muramidase | 2 | 1983 | 47 | 0.010 |
Why?
|
| Genetic Markers | 2 | 1986 | 131 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 1985 | 10 | 0.010 |
Why?
|
| DNA Replication | 1 | 2007 | 249 | 0.010 |
Why?
|
| Herpesvirus 2, Human | 1 | 2005 | 14 | 0.010 |
Why?
|
| Protein Folding | 1 | 2006 | 269 | 0.010 |
Why?
|
| Haptens | 2 | 1974 | 14 | 0.010 |
Why?
|
| Vitamin E | 1 | 1985 | 55 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1985 | 143 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 350 | 0.010 |
Why?
|
| Dithionite | 1 | 1984 | 2 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2004 | 16 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2005 | 85 | 0.010 |
Why?
|
| Maltose-Binding Proteins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Butyric Acid | 1 | 2003 | 2 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1984 | 49 | 0.010 |
Why?
|
| Phospholipids | 1 | 2004 | 82 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 2 | 1999 | 34 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2003 | 39 | 0.010 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 1983 | 9 | 0.010 |
Why?
|
| Registries | 1 | 1988 | 904 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 114 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 1010 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 1981 | 249 | 0.010 |
Why?
|
| Radiation Chimera | 4 | 1980 | 61 | 0.010 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 1983 | 1 | 0.010 |
Why?
|
| DNA Probes | 1 | 2003 | 33 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 325 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 239 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2003 | 74 | 0.010 |
Why?
|
| Lactoferrin | 1 | 1983 | 37 | 0.010 |
Why?
|
| Flow Cytometry | 3 | 1990 | 675 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1216 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 2166 | 0.010 |
Why?
|
| Methylmannosides | 1 | 1982 | 2 | 0.010 |
Why?
|
| Ethylenes | 1 | 1982 | 5 | 0.010 |
Why?
|
| Latex | 1 | 1982 | 5 | 0.010 |
Why?
|
| Hydroxyl Radical | 1 | 1982 | 8 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 391 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 1982 | 754 | 0.010 |
Why?
|
| Autophagy | 1 | 1985 | 237 | 0.010 |
Why?
|
| Chromatin | 1 | 2007 | 643 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2008 | 830 | 0.010 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2002 | 144 | 0.010 |
Why?
|
| Fluoresceins | 2 | 1993 | 32 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 363 | 0.010 |
Why?
|
| Nucleotidases | 1 | 1981 | 1 | 0.010 |
Why?
|
| Osteosarcoma | 2 | 1979 | 59 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 2001 | 13 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2001 | 24 | 0.010 |
Why?
|
| Substantia Gelatinosa | 1 | 1981 | 1 | 0.010 |
Why?
|
| Hypnosis | 1 | 1981 | 3 | 0.010 |
Why?
|
| Endorphins | 1 | 1981 | 12 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2001 | 12 | 0.010 |
Why?
|
| Acupuncture Therapy | 1 | 1981 | 18 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1981 | 27 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1981 | 76 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 2003 | 723 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2001 | 71 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 352 | 0.010 |
Why?
|
| Ascaris | 3 | 1974 | 4 | 0.010 |
Why?
|
| Mice, Inbred A | 3 | 1974 | 20 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 70 | 0.010 |
Why?
|
| Hexosephosphates | 1 | 1980 | 1 | 0.010 |
Why?
|
| Passive Cutaneous Anaphylaxis | 3 | 1974 | 6 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1981 | 110 | 0.010 |
Why?
|
| Friend murine leukemia virus | 1 | 1980 | 1 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1980 | 6 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 198 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2001 | 153 | 0.010 |
Why?
|
| Chickens | 3 | 1974 | 94 | 0.010 |
Why?
|
| Analgesics | 1 | 1981 | 103 | 0.010 |
Why?
|
| Ovalbumin | 3 | 1974 | 116 | 0.010 |
Why?
|
| NAD | 1 | 1980 | 53 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1980 | 25 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1981 | 152 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2001 | 245 | 0.010 |
Why?
|
| Quinacrine Mustard | 1 | 1979 | 1 | 0.010 |
Why?
|
| Y Chromosome | 1 | 1979 | 3 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1981 | 182 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1980 | 233 | 0.010 |
Why?
|
| Quinacrine | 1 | 1979 | 3 | 0.010 |
Why?
|
| Methods | 1 | 1979 | 40 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 53 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 3 | 1986 | 26 | 0.010 |
Why?
|
| Interphase | 1 | 1979 | 68 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1979 | 65 | 0.010 |
Why?
|
| Base Pairing | 1 | 1999 | 45 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1981 | 200 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1978 | 7 | 0.010 |
Why?
|
| Fluorescence | 1 | 1979 | 93 | 0.010 |
Why?
|
| Phosphoserine | 1 | 1998 | 10 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1978 | 87 | 0.010 |
Why?
|
| Cell Adhesion | 3 | 1986 | 216 | 0.010 |
Why?
|
| Risk | 1 | 1979 | 380 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1980 | 299 | 0.010 |
Why?
|
| Aminocaproates | 2 | 1974 | 2 | 0.010 |
Why?
|
| gamma-Globulins | 2 | 1974 | 10 | 0.010 |
Why?
|
| Tritium | 2 | 1974 | 22 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1981 | 338 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 253 | 0.010 |
Why?
|
| Immunization, Secondary | 2 | 1974 | 51 | 0.010 |
Why?
|
| Immunization, Passive | 2 | 1974 | 96 | 0.010 |
Why?
|
| Immunization | 2 | 1974 | 138 | 0.010 |
Why?
|
| Cattle | 2 | 1974 | 320 | 0.010 |
Why?
|
| Ionophores | 1 | 1996 | 11 | 0.010 |
Why?
|
| Receptors, Laminin | 1 | 1996 | 17 | 0.010 |
Why?
|
| Ionomycin | 1 | 1996 | 16 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1996 | 20 | 0.010 |
Why?
|
| Integrin alpha6 | 1 | 1996 | 20 | 0.010 |
Why?
|
| Growth Substances | 1 | 1996 | 34 | 0.010 |
Why?
|
| Fibronectins | 1 | 1996 | 44 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 1996 | 32 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1996 | 146 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1974 | 891 | 0.010 |
Why?
|
| Collagen | 1 | 1996 | 134 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1996 | 195 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1996 | 345 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1995 | 38 | 0.010 |
Why?
|
| Erythrocytes | 2 | 1986 | 153 | 0.010 |
Why?
|
| Pollen | 1 | 1974 | 5 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1974 | 102 | 0.010 |
Why?
|
| Endotoxins | 1 | 1974 | 81 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1992 | 11 | 0.010 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 1992 | 19 | 0.010 |
Why?
|
| Graft vs Host Reaction | 2 | 1982 | 7 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 162 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 1974 | 289 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 1992 | 150 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1992 | 134 | 0.010 |
Why?
|
| Antibodies | 1 | 1992 | 187 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1993 | 284 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1993 | 327 | 0.010 |
Why?
|
| Vacuoles | 1 | 1990 | 31 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1990 | 35 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1989 | 3 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 204 | 0.000 |
Why?
|
| Peptides | 1 | 1992 | 599 | 0.000 |
Why?
|
| Calcimycin | 1 | 1987 | 19 | 0.000 |
Why?
|
| Histamine | 1 | 1987 | 21 | 0.000 |
Why?
|
| Proteoglycans | 1 | 1987 | 35 | 0.000 |
Why?
|
| Arachidonic Acid | 1 | 1987 | 38 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1987 | 27 | 0.000 |
Why?
|
| Glycosaminoglycans | 1 | 1987 | 20 | 0.000 |
Why?
|
| Mast Cells | 1 | 1987 | 53 | 0.000 |
Why?
|
| Cell Separation | 1 | 1987 | 148 | 0.000 |
Why?
|
| Paternity | 1 | 1986 | 1 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1986 | 43 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1986 | 293 | 0.000 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1985 | 29 | 0.000 |
Why?
|
| Hemocyanins | 2 | 1974 | 24 | 0.000 |
Why?
|
| Cyanides | 1 | 1981 | 3 | 0.000 |
Why?
|
| Carbocyanines | 1 | 1981 | 31 | 0.000 |
Why?
|
| Benzothiazoles | 1 | 1981 | 20 | 0.000 |
Why?
|
| Cesium Radioisotopes | 1 | 1981 | 2 | 0.000 |
Why?
|
| Erythrocyte Aging | 1 | 1981 | 2 | 0.000 |
Why?
|
| Thymidine | 1 | 1981 | 25 | 0.000 |
Why?
|
| Mice, Inbred AKR | 1 | 1981 | 12 | 0.000 |
Why?
|
| Biopsy, Needle | 1 | 1981 | 137 | 0.000 |
Why?
|
| Mice, Inbred NZB | 1 | 1981 | 21 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1980 | 18 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1981 | 174 | 0.000 |
Why?
|
| Rauscher Virus | 1 | 1980 | 2 | 0.000 |
Why?
|
| Helper Viruses | 1 | 1980 | 5 | 0.000 |
Why?
|
| Antilymphocyte Serum | 1 | 1980 | 22 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1981 | 194 | 0.000 |
Why?
|
| Glucuronidase | 1 | 1978 | 25 | 0.000 |
Why?
|
| Radiography | 1 | 1979 | 557 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1974 | 11 | 0.000 |
Why?
|
| Histocompatibility | 1 | 1974 | 8 | 0.000 |
Why?
|
| Aluminum | 1 | 1974 | 14 | 0.000 |
Why?
|
| Glutamates | 1 | 1974 | 13 | 0.000 |
Why?
|
| Immunogenetics | 1 | 1974 | 4 | 0.000 |
Why?
|
| Lysine | 1 | 1974 | 95 | 0.000 |
Why?
|